(Q44905354)

7 December 2017

Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases (English)

1 reference

7 December 2017

Charles A Peloquin

1

1 reference

7 December 2017

Shaun E Berning

2

1 reference

7 December 2017

Annette T Nitta

3

1 reference

7 December 2017

Patricia M Simone

4

1 reference

7 December 2017

Marian Goble

5

1 reference

7 December 2017

Gwen A Huitt

6

1 reference

7 December 2017

Michael D Iseman

7

1 reference

7 December 2017

James L Cook

8

1 reference

7 December 2017

Douglas Curran-Everett

9

1 reference

7 December 2017

language of work or name

English

0 references

publication date

5 May 2004

1 reference

Clinical Infectious Diseases

7 December 2017

1 reference

7 December 2017

38

1 reference

7 December 2017

11

1 reference

7 December 2017

1538-1544

1 reference

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

7 December 2017

1 reference

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

21 January 2018

1 reference

Once-daily aminoglycoside therapy

21 January 2018

1 reference

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

21 January 2018

1 reference

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 January 2018

1 reference

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

A critical reevaluation of the "therapeutic range" of aminoglycosides

21 January 2018

1 reference

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

21 January 2018

1 reference

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Therapeutic drug monitoring in the treatment of tuberculosis

21 January 2018

1 reference

Therapeutic initiatives for the avoidance of aminoglycoside toxicity

21 January 2018

1 reference

Aminoglycoside-induced hearing loss in humans

21 January 2018

1 reference

An individualized, sensitive frequency range for early detection of ototoxicity.

21 January 2018

1 reference

The nephrotoxicity of antimicrobial agents (second of three parts).

21 January 2018

1 reference

Determinants of efficacy and toxicity of aminoglycosides

21 January 2018

1 reference

Familial streptomycin ototoxicity in a South African family: a mitochondrial disorder

21 January 2018

1 reference

Aminoglycoside ototoxicity in the human

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/420742

1 reference

7 December 2017

1 reference